Vasovagal reactions after COVID-19 vaccination in Japan

Vaccine. 2022 Sep 29;40(41):5997-6000. doi: 10.1016/j.vaccine.2022.08.056. Epub 2022 Aug 25.

Abstract

Coronavirus disease 2019 (COVID-19) vaccine administration started in February 2021 in Japan. As of December 2021, approximately 75% of the population aged ≥12 years had received two doses of vaccine. We conducted a study to investigate vasovagal reactions (VVR) after COVID-19 vaccination using data on adverse events following immunization. The crude reporting rate of VVR (cases/1,000,000 doses) after vaccination was 9.6 in all age groups combined, and was more frequent in the younger age groups: 28.6 and 37.2 in individuals aged 10-19 years and 20-29 years, respectively. In individuals aged 10-29 years, the rate was similar in males and females (33.0 and 34.2, respectively, p = 0.53); but was higher after dose 1 than after dose 2 (57.4 and 8.8, respectively, p < 0.001). Based on these results, caution needs to be exercised when vaccinating adolescents and young adults, especially with dose 1 of COVID-19 vaccines.

Keywords: Adolescents; Adverse event following immunization; COVID-19 vaccination; Immunization stress-related responses; Vasovagal reaction; Young adults.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Child
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Syncope, Vasovagal* / chemically induced
  • Vaccination / adverse effects
  • Young Adult

Substances

  • COVID-19 Vaccines